These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33687453)

  • 1. Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity.
    Henderson LM; Rivera MP; Basch E
    JAMA; 2021 Mar; 325(10):939-941. PubMed ID: 33687453
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk-based lung cancer screening eligibility criteria: towards implementation.
    Ten Haaf K
    Lancet Oncol; 2022 Jan; 23(1):13-14. PubMed ID: 34902333
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
    Hüsing A; Kaaks R
    Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events.
    Lu MT; Onuma OK; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    Circulation; 2016 Sep; 134(12):897-9. PubMed ID: 27647299
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung Cancer Screening Eligible?
    Yeboah J
    Circulation; 2018 Dec; 138(25):2867-2868. PubMed ID: 30566015
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening Smokers for Lung Cancer with Low-Dose CT Decreases Lung Cancer Mortality.
    Barry HC
    Am Fam Physician; 2021 May; 103(10):630. PubMed ID: 33983004
    [No Abstract]   [Full Text] [Related]  

  • 7. Expansion of Guideline-Recommended Lung Cancer Screening Eligibility: Implications for Health Equity of Joint Screening and Cessation Interventions.
    Salloum RG; Braithwaite D
    J Thorac Oncol; 2022 Jan; 17(1):13-15. PubMed ID: 34930605
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021.
    Shusted CS; Evans NR; Kane GC; Juon HS; Barta JA
    JAMA Netw Open; 2022 Jun; 5(6):e2217578. PubMed ID: 35704319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
    Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
    Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward Racial Equity in Lung Cancer Screening Eligibility.
    Kathuria H; Wiener RS
    J Clin Oncol; 2024 Jun; 42(17):2001-2004. PubMed ID: 38537157
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining Equity in Eligibility for Cancer Screening.
    Robbins HA; Johansson M
    JAMA Oncol; 2020 Jan; 6(1):156. PubMed ID: 31697333
    [No Abstract]   [Full Text] [Related]  

  • 12. Age, Sex, Smoking, and Race: Is Progress Being Made in Lung Cancer Screening Eligibility?
    Sears CR; Rivera MP
    Chest; 2021 Jul; 160(1):31-33. PubMed ID: 34246372
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial.
    Iaccarino JM; Steiling KA; Wiener RS
    Ann Am Thorac Soc; 2018 Dec; 15(12):1493-1495. PubMed ID: 30199643
    [No Abstract]   [Full Text] [Related]  

  • 14. Adherence to Lung Cancer Screening: What Exactly Are We Talking About?
    Sakoda LC; Henderson LM; Rivera MP
    Ann Am Thorac Soc; 2021 Dec; 18(12):1951-1952. PubMed ID: 34380008
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.
    Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ
    Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Pack-Year Eligibility for Lung Cancer Screening Using 2 Yes or No Questions.
    Rendle KA; Steltz JP; Cohen S; Schapira MM; Wender RC; Bekelman JE; Vachani A
    JAMA Netw Open; 2023 Aug; 6(8):e2327363. PubMed ID: 37548980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT screening for lung cancer: Are we ready to implement in Europe?
    Balata H; Evison M; Sharman A; Crosbie P; Booton R
    Lung Cancer; 2019 Aug; 134():25-33. PubMed ID: 31319989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising eligibility criteria for lung cancer screening.
    Crosbie PAJ; Callister MEJ
    Lancet Respir Med; 2023 Aug; 11(8):665-666. PubMed ID: 37030306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is screening for lung cancer in high-risk subjects using low-dose CT scan effective in reducing mortality?].
    Lanthier L; Bouchard N; Huard G; Plourde ME; Cauchon M
    Rev Med Interne; 2020 May; 41(5):350-351. PubMed ID: 32312589
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines.
    Potter AL; Yang CJ; Woolpert KM; Puttaraju T; Suzuki K; Palmer JR
    JAMA Oncol; 2022 Jan; 8(1):163-164. PubMed ID: 34817564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.